Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Jinxin Fertility Group Limited ᎀؚ͛ಟᔼᐕණྠϞࠢʮ̡*

(Incorporated under the laws of the Cayman Islands with limited liability)

(Stock Code: 1951)

FURTHER INFORMATION

IN RELATION TO CHANGE OF DIRECTORS

Reference is made to the announcement dated March 28, 2021 (the "Announcement") in relation to, among other, the appointment of Dr. Geng Lihong ("Dr. Geng") as an executive Director with effect from March 28, 2021; and the appointment of Ms. Yan Xiaoqing ("Ms. Yan") as a non-executive Director with effect from March 28, 2021. Unless otherwise specified, capitalized terms used herein have the same meanings as those defined in the Announcement.

The Board herewith provides the following information of Dr. Geng and Ms. Yan as required to be disclosed pursuant to Rules 13.51(g) of the Listing Rules:

Dr. Geng was appointed as an executive Director with effect from March 28, 2021. As an employee of the Group, Dr. Geng is entitled to a remuneration in the sum of RMB1,321,345 per annum, with bonus payable at the discretion of the Board. The Board and the Remuneration Committee have determined that for the time-being no additional emoluments will be payable to Dr. Geng in taking on additional responsibility as Director. Her remuneration will be further reviewed by the Board and the Remuneration Committee at regular intervals.

Ms. Yan was appointed as a non-executive Director with effect from March 28, 2021. As an employee of the Group, Ms. Yan is entitled to a remuneration in the sum of RMB600,000 per annum, with bonus payable at the discretion of the Board. The Board and the Remuneration Committee have determined that for the time-being no additional emoluments will be payable to Ms. Yan in taking on additional responsibility as Director. Her remuneration will be further reviewed by the Board and the Remuneration Committee at regular intervals.

Saved for the aforesaid, all information in the Announcement remains unchanged.

By order of the Board Jinxin Fertility Group Limited

Zhong Yong Chairman

Hong Kong, March 30, 2021

As at the date of this announcement, the Board of Directors of the Company comprises Mr. Zhong Yong, Dr. John G. Wilcox, Mr. Dong Yang and Dr. Geng Lihong, as executive Directors; Mr. Fang Min, Ms. Hu Zhe and Ms. Yan Xiaoqing, as non-executive Directors; and Dr. Chong Yat Keung, Mr. Lim Haw Kuang, Mr. Wang Xiaobo and Mr. Ye Changqing, as independent non-executive Directors.

* For identification purpose only

Attachments

  • Original document
  • Permalink

Disclaimer

Jinxin Fertility Group Ltd. published this content on 30 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2021 09:38:05 UTC.